Peter Kemp

Peter Kemp is a British patient advocate for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS] and lyme disease. He has been an outspoken critic of the PACE trial.

PACE trial

 * Sep 14 2016, PACE Trial SF36PF ‘Improved’. New data shows that the criteria is as useless as ‘Normal Range’ - Graph
 * Sep 14 2016, PACE Trial Normal Range Fatigue – Another Untenable Construct - Graph
 * Sep 10 2016, The PACE Trial ‘Normal Range’ – an Untenable Construct
 * Sep 10 2016, PACE Trial Participants – were they exploited?
 * Feb 17 2016, The PACE Trial: Making up Recovery to suit themselves
 * Feb 2016, PACE trial analysis
 * Jun 27 2011, British Medical Journal - "Assumptions, assumptions." Rapid response by Peter Kemp in response to "Dangers of research into chronic fatigue syndrome".

Online presence

 * Blog
 * Twitter
 * Website